Search PubMed⌕ Search

Biomedical subjects

M Ferrario

Publications and source records attributed to M Ferrario.

At least 73 records · Page 4Linked to original sources
PubMed1992

[Drop in cardiovascular and coronary mortality in Lombardia, 1969-1987. Evaluation of reliability of the estimates and possible explaining hypothesis].

The results of the present analysis indicate, from 1969 to 1987, a sharp and stable decline in cardiovascular (CVD) mortality in Italians aged 35-74 years (37.6% in males 53.6% in females). These trends were responsible for consistent reductions of total mortality (27.5% and 38% in the two gender groups, respectively), and for the increase of life expectancy. The decrease involved the two major components of CVD mortality, i.e. coronary heart disease (CHD) (23% in males and 44% in females) and cerebrovascular diseases (Stroke) (42.6% in the former and 51% in latter gender group). All these mortality decrements have been higher in the Lombardia Region. Comparing age-adjusted mortality rates in 1968 and 1987, it was possible to estimate that 23,040 deaths were saved in one year among the residents of this northern part of Italy, and the decrease of CHD mortality was responsible for about 30% of the total national decrement of CHD deaths, within comparable age strata. This is attributable both to the higher rates registered at the beginning of the studied period, and to the sharper decline observed. The social impact, in terms of reduction of deaths, was prominent for males. Among the northern male population, the amount of prevented deaths due to CHD and Stroke was equivalent (2072 vs 2172). Data from a MONICA Collaborating Center, located in the region--Area Brianza--, allow us to estimate, for coronary diagnoses reported on death certificates in the 1980s, acceptable levels of accuracy (Cohen's Kappa of .35, with 99% CI .27-.43) and sensitivity (87%). In comparison with earlier estimates carried out in the late 1970s, it is possible to hypothesize an increase of sensitivity over time for certified myocardial infarction diagnoses, which could have contributed to the underestimation of the observed decrements. In dealing with estimates of the reasons for these declines, only suggestions could be addressed because results of specific and comprehensive studies are not presently available. By comparing MONICA data with the results obtained in earlier surveys, it is possible to estimate that about 20 to 30% of the CHD decline, which occurred in the Region, might be attributed to the decrease of in-hospital coronary case-fatality. Moreover, major coronary risk factors (total cholesterol, blood pressure and cigarette smoking) show parallel positive changes, but their contribution in predicting the CHD downfall is difficult to evaluate on the basis of existing data.(ABSTRACT TRUNCATED AT 400 WORDS)

Adult↗
PubMed1992

[Comparison of results of echo-dobutamine and ECG-dobutamine tests in the diagnosis of coronary disease].

The aim of the study was to compare the results of 2D-Echocardiographic (ECHO) vs 12-lead Electrocardiographic (ECG) monitoring during Dobutamine (DOB) infusion performed as a stress test in patients referred for the evaluation of chest pain of suspected ischemic origin. Fourty-seven consecutive patients, 40 m and 7 f, mean age 52 +/- 9 years, were studied after interruption of any antianginal therapy. DOB was infused in 5-minute stages with incremental doses of 5 mcg/kg/min up to a maximal dose of 40 mcg/kg/min. 2D-ECHO monitoring could not be performed in 3 out of 47 patients because of a poor acoustic window. Thus, the overall feasibility was 94% for 2D-ECHO DOB test vs 100% for ECG DOB test (p = ns). The ECG and 2D-ECHO findings were compared in the remaining 44 patients. Criteria for positivity were: transient regional dyssynergy absent or of lesser degree in the baseline examination for 2D-ECHO; ST-segment shift > 0.1 mV from baseline for ECG. The test was stopped when a regional wall motion abnormality developed even in the absence of significant ECG changes. Angiographically assessed coronary artery disease (CAD) was considered significant when a > 50% reduction of the luminal diameter in at least 1 major coronary vessel occurred. There were 10/44 patients with no significant CAD and 34/44 patients with CAD; 16 had single, 18 double or triple and/or left main vessel disease.(ABSTRACT TRUNCATED AT 250 WORDS)

Adult↗
PubMed1991

Ambulatory blood pressure normalcy: the PAMELA Study.

Although ambulatory blood pressure monitoring is gaining in popularity, it still has important limitations in clinical use, particularly for the definition and diagnosis of hypertension. Various attempts have been made to calculate 'normal' or 'reference' values for ambulatory blood pressure, mostly by 24-h non-invasive monitoring in groups of 'normal' subjects. The most appropriate approach, however, is to compare 24-h ambulatory blood pressure values and casual or clinic blood pressure values in a random sample of a suitably large population. The PAMELA Study has been planned to obtain an epidemiological evaluation of 24-h ambulatory blood pressure values, and its design is described here. In the city of Monza, 2400 subjects aged between 25 and 64 years have been randomly selected according to World Health Organization Monitoring Cardiovascular Diseases (WHO-MONICA) project criteria within sex and age strata. In these subjects, clinic blood pressure, random-zero blood pressure, ambulatory blood pressure (24-h monitoring with SpaceLabs 90207; Redmond, Washington, USA), home blood pressure, electrocardiographic and echocardiographic indices, cardiovascular risk factors and psychological variables are being measured.

Adult↗
PubMed1991

Lessons from the MONICA study in northern Italy.

Consistent reductions in cardiovascular mortality have been demonstrated in recent years in most developed countries. From official mortality data for the period 1969-1987, we have recently detected a similar trend in Italy. The decline started in the second half of the 1970s and was more pronounced in the northern part of the country. To identify the determinants of these trends, the World Health Organization Monitoring Cardiovascular Diseases (WHO MONICA) Project was set up. There are 39 participating centers spread over 26 countries worldwide. In the Brianza area, one of the three Italian areas that joined the project from the beginning, two population surveys and 5 years of mortality records have been completed. Provisional results and methodological issues of quality control and data collection are discussed in this paper, together with the implications for prevention and treatment.

Adult↗
PubMed1991

Dobutamine versus dipyridamole echocardiography in coronary artery disease.

Dobutamine and dipyridamole echocardiography are gaining popularity as exercise-independent stress tests for the diagnosis of coronary artery disease. To compare the feasibility, sensitivity, and specificity of dobutamine echocardiography to dipyridamole echocardiography, we conducted both tests, on different days and in random order, on 35 patients with chest pain and suspected coronary artery disease. Dobutamine was administered in scalar doses up to 40 micrograms/kg per minute and dipyridamole up to 0.84 mg/kg for 10 minutes. Dobutamine echocardiography testing was positive in eight of 16 (50%) patients with single-vessel disease and in 11 of 12 (92%) patients with multivessel disease, resulting in an overall sensitivity of 68% for the presence of coronary artery disease. Dipyridamole echocardiography testing showed the same sensitivity as dobutamine in patients with multivessel disease but a lower sensitivity (31%) in single-vessel disease, resulting in an overall sensitivity of 57%. The specificity of both tests was 100%. An ST segment shift of more than 1 mm compared with baseline was documented in 74% of the positive dobutamine echocardiography tests and in 81% of the positive dipyridamole echocardiography tests. No major complications occurred during both tests. Ventricular arrhythmias occurred in 11 patients with dobutamine and in none with dipyridamole (31% versus 0%, p less than 0.001). Thus, in our selected population dobutamine echocardiography testing demonstrated a similar overall sensitivity and specificity for the diagnosis of coronary artery disease compared with dipyridamole, with a slightly better sensitivity for single-vessel disease but a greater arrhythmogenic potential.

Angiography↗
PubMed1990

Effects of atrial pacing and dipyridamole administration on coronary hemodynamics of collateralized myocardial regions in stable angina pectoris.

Great cardiac vein blood flow by thermodilution and great cardiac vein oxygen saturation were measured in 14 patients with stable exertional angina and an angiographic pattern of complete occlusion of the proximal left anterior descending artery retrogradely filled by collateral vessels supplying still viable myocardium. Measurements were obtained under control conditions, at peak atrial pacing and after dipyridamole administration (0.56 mg/kg intravenously over 4 minutes). Both stress tests induced ischemic electrocardiographic changes in all patients, but dipyridamole administration resulted in greater ST-segment depression in 11 patients (1.6 +/- 0.5 vs 2.4 +/- 1.6 mm, p less than 0.05) and transient ST-segment elevation in 3 patients. Dipyridamole provoked ischemia at a lower value of rate-pressure product (145.3 +/- 30.6 vs 202.9 +/- 36.6 beats/min . mm Hg . 10(-2), p less than 0.0005) and anterior region myocardial oxygen consumption (9.32 +/- 4.76 vs 11.39 +/- 3.91 ml/min, p less than 0.05), despite a greater increase in great cardiac vein flow (139.4 +/- 45 vs 93 +/- 27.4 ml/min, p less than 0.0025) and a greater decrease in the calculated index of anterior region coronary resistance (0.87 +/- 0.27 vs 1.46 +/- 0.43 mm Hg/ml/min, p less than 0.0005). Moreover, great cardiac vein oxygen saturation increased more significantly during dipyridamole-induced ischemia than at peak pacing (63 +/- 12 vs 35 +/- 8%, p less than 0.0005).(ABSTRACT TRUNCATED AT 250 WORDS)

Angina Pectoris↗
PubMed1990

Usefulness of the hyperventilation test in stable exertional angina pectoris in selecting medical therapy.

To assess the prevalence of abnormal coronary vasoconstriction in stable exertional angina and to evaluate whether the presence of increased coronary tone may have therapeutic implications, we studied 83 consecutive patients with typical exertional angina, positive response to exercise stress testing and documented coronary artery disease. Abnormal coronary vasoconstriction was induced by a hyperventilation test in 16 patients (group I) while the remaining 67 had a negative response (group II). No differences were observed between the 2 groups with regard to clinical, exercise and angiographic data. All group I patients and 16 patients in group II repeated hyperventilation and exercise tests after the administration of dihydropyridine-type calcium antagonists (7 patients nifedipine, 9 patients felodipine). After treatment 15 of 16 group I patients had a negative response to the hyperventilation test. The total exercise duration was significantly increased (278 +/- 183 vs 554 +/- 248 seconds; p less than 0.001) with higher values of rate pressure product at peak exercise (168 +/- 47 vs 235 +/- 67 mm Hg x beats/min/100; p less than 0.0025). In group II no significant differences were observed between pre- and posttreatment values for total exercise duration (244 +/- 210 vs 308 +/- 243 seconds) and rate pressure product at peak exercise (170 +/- 46 vs 188 +/- 56 mm Hg x beats/min/100). These data show that the hyperventilation test can be used to select a subset of patients with stable exertional angina and detectable abnormal coronary vasoconstriction who will improve their exercise tolerance with coronary vasodilator treatment.

Angina Pectoris↗
PubMed1990

Variable response to atrial pacing after intravenous propranolol in patients with stable exertional angina.

The effect of propranolol administration on regional coronary haemodynamics were investigated in 14 patients with stable exertional angina and isolated left anterior descending artery disease. Thermodilution was used to measure great cardiac vein flow (GCVF) and anterior regional coronary resistance (ARCR) under control conditions, at peak atrial pacing, after i.v. propranolol administration (0.1 mg kg-1) and at the peak of repeated atrial pacing. Propranolol did not change peak pacing heart rate, systolic blood pressure or double product. Peak pacing GCVF decreased slightly but non-significantly after drug administration from 84 +/- 20 to 79 +/- 24 ml min-1, while ARCR increased, but again non-significantly, from 1.36 +/- 0.44 to 1.45 +/- 0.45. Analysis of individual patient responses revealed that propranolol prolonged peak pacing time and hence peak pacing heart rate (from 126 +/- 24 to 140 +/- 23 beats min-1, P less than 0.05) in five patients. In such patients, peak pacing systolic blood pressure was lower than the pre-propranolol atrial pacing (145 +/- 35 vs 165 +/- 33, P less than 0.001) so that double product remained unchanged. Moreover, peak pacing ARCR did not change after propranolol (pre-propranolol 1.47 +/- 0.46, after propranolol 1.40 +/- 0.56 mmHg.ml-1.min, P = ns) while it increased significantly in the nine patients who did not improve after the drug (before propranolol 1.30 +/- 0.44, after propranolol 1.48 +/- 0.41 mmHg.ml-1.min, P less than 0.02). These data suggest that the response to atrial pacing after i.v. propranolol administration is variable as some patients tolerate higher heart rates while others do not.(ABSTRACT TRUNCATED AT 250 WORDS)

Aged↗
PubMed1990

Methods of total cholesterol measurement in the baseline survey of the WHO MONICA Project.

In the WHO MONICA Project (Monitoring of Trends and Determinants of Cardiovascular Disease) total cholesterol was measured in representative samples from 51 study populations in 26 countries. The biochemical measurements were done locally by the collaborating centres' laboratories. Differences in measurement procedures among the populations were found in the following factors: fasting status, posture of the subject, tourniquet use, use of serum or plasma, storage conditions, and the analytical method itself. This paper gives an overview of the methods used, and discusses the possible effects of the differences on the comparability of the results. The use of a posture other than that recommended and the use of EDTA (ethylene diaminetetraacetate) plasma are considered to be the most important factors, and were found in 9 out of the 51 populations.

Adult↗
PubMed1990

[Comparison of two-dimensional echocardiography and hemodynamic monitoring in acute myocardial infarct].

The aim of this study was to assess if in patients with acute myocardial infarction, two-dimensional echocardiographic asynergy index is correlated to hemodynamic parameters. Furthermore, we compared how reliable the 2 methods are to identify patients at a high risk of developing early left ventricular failure. Fifty-four consecutive patients (43 males, 11 females, mean age: 61 +/- 13 years with acute myocardial infarction were studied using hemodynamic monitoring and 2D-echocardiography within 24 hours from admission. The 2D-echo asynergy index, calculated on a 14-segment left ventricular model, was significantly correlated to heart rate (r = 0.49, p less than 0.001), pulmonary capillary wedge pressure (r = 0.47, p less than 0.001), systemic vascular resistance (r = 0.47, p less than 0.001), cardiac index (r = -0.46, p less than 0.001) and left ventricular stroke work index (r = -0.63, p less than 0.001). Both the asynergy index and the hemodynamic parameters were correlated to Killip clinical classification. In the sub-group of 46 patients initially classified as belonging to Killip class I or II, the patients who later developed left ventricular failure or those in whom it worsened showed a higher asynergy index and a greater impairment of left ventricular function when compared to the patients with an uncomplicated clinical course. The sensitivity of an asynergy index greater than or equal to 1 in predicting early cardiac failure was 75%, the specificity was 64%, the positive predictive value was 43% and the negative predictive value was 88%.(ABSTRACT TRUNCATED AT 250 WORDS)

Adult↗
PubMed1990

[Expansion of the infarct area in anterior myocardial infarct: a short-term clinical and echocardiographic study].

Forty-five patients with a first anterior myocardial infarction were studied by serial two-dimensional echocardiographic examinations to evaluate the incidence, short-term evolution and clinical significance of infarct expansion. Infarct expansion was found in 26 patients (58%); in 22 cases it was detected at the first examination 24 hours after the onset of symptoms, while in the other 4 it developed later. In 20 (77%) patients expansion involved only the septal and apical regions, while in 6 (23%) it extended to the antero-lateral wall. Two out of 22 patients with early expansion died of cardiogenic shock; expansion of the infarcted area progressively increased in 10 of the remaining 20 patients and remained stable in the other 10. Compared to the patients without expansion those with expansion had a higher CK peak level, a greater number of pathological Q waves and a greater echocardiographic asynergy score; moreover, in-hospital mortality and the incidence of left ventricular failure were higher in the group with expansion (8% vs 0% and 54% vs 10% respectively). Thus our results show that in patients with anterior infarction, expansion is a frequent event which usually develops early and may have a progressive course; infarct expansion, especially when it is large and progressive, is associated with a high incidence of early left ventricular failure and has a poor prognostic significance.

Adult↗
PubMed1989

Long-term survival and risk stratification in patients with angina at rest undergoing medical treatment.

In order to determine those factors which influence long-term prognosis in patients with angina at rest associated with transient ST-segment changes, 217 patients undergoing medical treatment were followed for a mean of 39 months. All patients underwent coronary arteriography. Univariate analysis identified 12 variables significantly related to prognosis. These were disease of the left main coronary artery; the number of diseased vessels; left ventricular end-diastolic pressure; ejection fraction; baseline electrocardiogram; presence of prior myocardial infarction; ST-segment depression and ventricular arrhythmias during pain; disease of the proximal anterior descending coronary artery; crescendo angina; hypertension; and age. Use of the Cox regression model for survival analysis revealed only 3 variables which were independent predictors of prognosis. They were disease of the left main coronary artery; the number of diseased vessels and left ventricular end-diastolic pressure. The model allowed stratification of patients into 3 groups. Survival at 3 years was 98% in the low risk group; 82% in the intermediate risk group; and 58% in the high risk group. These data indicate that disease of the left main coronary artery, the number of diseased vessels and left ventricular end-diastolic pressure are the independent predictors of prognosis in angina at rest. These variables may allow stratification of patients into groups having different long-term survivals.

Adult↗
PubMed1989

Calcium antagonists after acute myocardial infarction.

Studies dealing with the evaluation of efficacy and safety of calcium-channel blocking agents in patients with myocardial infarction are not completely exhaustive. In this setting, three major issues have to be considered: the treatment of postinfarction angina, the prevention of sudden death and fatal or nonfatal reinfarction, and the potentially harmful inotropic action of these drugs. Calcium-channel blocking agents may exert their anti-ischemic effect either by increasing myocardial oxygen supply or by reducing myocardial oxygen demand, or both. The drug of choice will depend on the physiopathological setting of the individual patient and on the responsiveness to each specific compound (verapamil, dilitiazem, or dihydropyridines). The potential dangerous cardiodepressant action of this class of drugs, well documented in vitro, is sizable in vivo only for some of them (verapamil and derivatives, much less for diltiazem), but not for dihydropyridines. Thus, it does not generally represent a definite contraindication for patients also with potentially impaired left ventricular function. Up to the present, a number of studies have failed to demonstrate any beneficial effect of nifedipine and verapamil in the secondary prevention of myocardial infarction. Only diltiazem proved to be effective in increasing survival in patients with non-Q-wave myocardial infarction without left ventricular dysfunction. These data suggest the need for a careful stratification of patients into subgroups, in order to clarify who could actually benefit by these drugs.

Calcium Channel Blockers↗